Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Thursday, 10 September 2026
AHPRA will pilot a registration-fee deferral option for Australian and New Zealand medical school graduates applying for provisional registr
Wednesday, 9 September 2026
BMC Medical retrospectively reported a recall of 20,160 Luna G3 APAP devices to the US Food and Drug Administration on 15 July 2026 because
Tuesday, 8 September 2026
GlaxoSmithKline Australia has again asked the Pharmaceutical Benefits Advisory Committee to lower National Immunisation Program eligibility
Sunday, 6 September 2026
Venlafaxine 75 mg immediate-release tablets are expected to be unavailable across the UK until November. The Department of Health and Social
Saturday, 5 September 2026
PBS-subsidised prescribing by registered nurses faces unresolved technical and workflow questions ahead of its planned 1 October start, acco
Friday, 4 September 2026
Almost half of overseas-trained GPs applying for specialist registration in Australia used the expedited pathway in 2025. From October 2024
Thursday, 3 September 2026
After Rural Generalist Medicine was recognised as a field of specialty practice, applications have now opened for eligible GPs to record spe
Wednesday, 2 September 2026
From 1 September, all GPs can initiate and manage PBS-subsidised hepatitis B and C treatment under the Highly Specialised Drugs program with
Tuesday, 1 September 2026
The STAREE trial found daily atorvastatin 40 mg reduced the risk of heart attack and stroke by 30% compared with placebo in independently li
Sunday, 30 August 2026
New environmental sustainability requirements in the RACGP’s sixth accreditation standards add cost and red tape without improving patient s